Two Chinese Companies Raising Around $630 Million in Total via Bond Offerings
By Megan Cheah
Two Hong Kong-listed companies are raising around $630 million in total through bond offerings, as more companies seek to tap debt capital markets to fund their businesses.
Pharmaron Beijing is planning to issue dollar-settled zero-coupon convertible bonds worth 2.18 billion yuan, equivalent to $324.3 million, it said Thursday. The bonds will mature around end-August next year, it said.
The Chinese contract research and manufacturing company, which provides services to the pharmaceutical and biotechnology industries, aims to use net proceeds from the deal to support its expansion, refinance some existing debt and for general corporate purposes.
Separately, China Nonferrous Mining is proposing to issue $300 million of zero-coupon convertible bonds due 2031. The Chinese miner is seeking to use the net proceeds to fund the construction of a sulfide ore resource development project in Zambia, the Beijing-based company said Thursday.
More Chinese companies are tapping Hong Kong's market as they seek different pools of capital to fund operations via share offerings and bond issuances. Hong Kong is widely seen as a gateway for foreign investors to allocate capital to Chinese assets, given the hurdles foreign capital faces in accessing the country's onshore markets.
Write to Megan Cheah at megan.cheah@wsj.com
(END) Dow Jones Newswires
August 26, 2026 23:41 ET (03:41 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for October
The 10 Best Companies to Invest in Now
3 Stocks to Invest In With More Room to Run
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
United States